Beijing QL Biopharmaceutical Co.,Ltd: Obesity trials

The registry lists 10 Obesity studies with Beijing QL Biopharmaceutical Co.,Ltd as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 6Phase 2 3Phase 3 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Zovaglutide (ZT002 Injection) in Participants With Hepatic Impairment and Healthy ParticipantsNot yet recruitingNCT07916194Phase 1
• A Study Evaluating Safety and Tolerability of Switching From Semaglutide to Zovaglutide in Adults With Obesity (HORIZON-SWITCH-SZ)Not yet recruitingNCT07812597Phase 2
• A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy AdultsActive, not recruitingNCT07697846Phase 1
• Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese ParticipantsActive, not recruitingNCT07550816Phase 1
• A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy ParticipantsActive, not recruitingNCT07443059Phase 1
• Dose-escalation and Food Effect Study of ZT006 in Healthy, Overweight and Obese ParticipantsCompletedNCT07307638Phase 1
• Efficacy and Safety of ZT006 in Overweight and Obese ParticipantsActive, not recruitingNCT07230132Phase 2
• A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)Active, not recruitingNCT07230119Phase 3
• A Study of ZT002 Injection With Subjects With Overweight or ObesityCompletedNCT07020884Phase 2
• A Study of ZT002 Injection in Participants With Overweight or ObesityCompletedNCT06371326Phase 1